Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00651911 · ClinicalTrials.gov registry record · Phase 4
Fasturtec TLS Treatment / Prophylysis
A Phase 4 study, sponsored by Sanofi.
- Completed
- Registry status
- Phase 4
- Development phase
- 45
- Enrollment target
NCT00651911 is a Phase 4 study that has completed, run by Sanofi. The registered enrollment target is 45 participants.
The verdict
NCT00651911, a Phase 4 study, has completed, sponsored by Sanofi.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 45 participants
- Enrollment target
Study Summary
An open-label study to determine the efficacy and safety of Rasburicase used for the prevention and treatment of tumor lysis syndrome
Interventions
- DRUG urate oxidase
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2003-07 |
| Est. Completion | 2004-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00651911
The ClinicalTrials.gov registry entry for NCT00651911 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanofi, which has 713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which urate oxidase is the first listed.
NCT00651911 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00651911 about?
NCT00651911 is a clinical study titled "Fasturtec TLS Treatment / Prophylysis". An open-label study to determine the efficacy and safety of Rasburicase used for the prevention and treatment of tumor lysis syndrome
What is the current status of trial NCT00651911?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 45 participants. The study started on 2003-07. Estimated completion is 2004-07.
What interventions are being tested in trial NCT00651911?
The interventions under investigation include: urate oxidase (DRUG).
Who is sponsoring clinical trial NCT00651911?
This trial is sponsored by Sanofi, which has 713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.